Larimar Therapeutics, Inc. (LRMR) financial statements (2022 and earlier)

Company profile

Business Address THREE BALA PLAZA EAST. SUITE 506
BALA CYNWYD, PA 19004
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:70,09792,63870,300118,100102,100129,200185,079
Cash and cash equivalents70,09768,14827,21149,33140,77732,35235,595
Short-term investments 24,49043,05068,73561,27596,842149,484
Other undisclosed cash, cash equivalents, and short-term investments  3934486 
Receivables      1,323
Prepaid expense944571     
Other undisclosed current assets1,1634,7431,2033,2302,8251,6991,708
Total current assets:72,20497,95271,503121,330104,925130,899188,110
Noncurrent Assets
Operating lease, right-of-use asset3,4063,9367,051
Property, plant and equipment1,0491,040821375528661902
Restricted cash and investments1,3391,3391,339    
Other noncurrent assets6694192057576194
Total noncurrent assets:6,4636,7349,231432585722996
TOTAL ASSETS:78,667104,68680,734121,762105,510131,621189,106
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,2528,4771,8227,8517,2936,30513,607
Accounts payable1,6602,6346323,5903,0202,5727,495
Accrued liabilities6,5925,8431,1904,2614,2733,7336,112
Debt  7,6595,455 3,5892,936
Restructuring reserve  2,709    
Other undisclosed current liabilities594515     
Total current liabilities:8,8468,99212,19013,3067,2939,89416,543
Noncurrent Liabilities
Long-term debt and lease obligation5,4086,00214,92015,18520,000 3,453
Long-term debt, excluding current maturities  8,46415,18520,000 3,453
Operating lease, liability5,4086,0026,456
Other undisclosed noncurrent liabilities(5,408)(6,002)     
Total noncurrent liabilities:5,4086,00214,92015,18520,000 3,453
Total liabilities:14,25414,99427,11028,49127,2939,89419,996
Stockholders' equity
Stockholders' equity attributable to parent64,41389,69253,62493,27178,217121,727169,110
Common stock18153737272727
Additional paid in capital180,645155,290449,903444,212367,825359,329348,961
Accumulated other comprehensive income (loss) 135(33)(58)(80)(207)
Accumulated deficit(116,250)(65,614)(396,351)(350,945)(289,577)(237,549)(179,671)
Total stockholders' equity:64,41389,69253,62493,27178,217121,727169,110
TOTAL LIABILITIES AND EQUITY:78,667104,68680,734121,762105,510131,621189,106

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues
(Sublease Income)
  112    
Gross profit:  112    
Operating expenses(50,465)(42,804)(45,654)(61,122)(52,999)(58,225)(73,813)
Other undisclosed operating loss  (112)    
Operating loss:(50,465)(42,804)(45,654)(61,122)(52,999)(58,225)(73,813)
Nonoperating income (expense)(171)322248(246)971347(473)
Investment income, nonoperating (10)1,9891,889996894438
Foreign currency transaction gain (loss), before tax  25(237)140(18)(105)
Interest and debt expense  (1,766)(1,898)(165)(529)(806)
Loss from continuing operations before equity method investments, income taxes:(50,636)(42,482)(47,172)(63,266)(52,193)(58,407)(75,092)
Other undisclosed income from continuing operations before income taxes  1,7661,898165529806
Net loss available to common stockholders, diluted:(50,636)(42,482)(45,406)(61,368)(52,028)(57,878)(74,286)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(50,636)(42,482)(45,406)(61,368)(52,028)(57,878)(74,286)
Comprehensive loss:(50,636)(42,482)(45,406)(61,368)(52,028)(57,878)(74,286)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)1682522127(172)
Comprehensive loss, net of tax, attributable to parent:(50,637)(42,481)(45,338)(61,343)(52,006)(57,751)(74,458)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: